Search This Blog

Tuesday, January 15, 2019

Cerecor congenital glycosylation IIc disorder treatment gets orphan status


The FDA granted orphan designation to Cerecor’s treatment of congenital disorder of glycosylation IIc, according to a post to the agency’s website. The Fly notes that this is the third notice of an orphan designation for a Cerecor treatment posted by the FDA today.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)